-
Your Cancer Guide
Choosing the Right ResponseTake a no-apologies approach in response to insensitive remarks.
by Hester Hill Schnipper
-
Caregiving With Confidence
Final WishesAdvance care planning can ease stress for both patients and caregivers.
by Carly O'Brien
-
Sound Advice
Fall 2016vol 06 | issue 03
Anxiety about cellphones and cancer, crowdfunding to help pay the bills, and the side effects of steroids. -
Forward Look
PET Scan OveruseStudy suggests lung and esophageal cancer survivors receive too many costly scans.
by Kendall K. Morgan
-
Your Cancer Guide
Weakening the Grip of Survivor GuiltGive yourself permission to appreciate your good fortune, despite knowing others who have not fared as well.
by Hester Hill Schnipper
-
Caregiving With Confidence
Finding Silver LiningsCaregiving is difficult, but it can bring rewards.
by Carly O'Brien
-
Healthy Habits
A Matter of TasteFollow tips for enjoying food despite treatment side effects.
by Brenda Conaway
-
Healthy Habits
Bolstering the BrainYoga helps lift the mental fog that often accompanies cancer treatment.
by Brenda Conaway
-
Q&A
Learning Emotional JudoPsychiatrist Andrew Roth helps prostate cancer patients identify and take control of their emotions.
by Kate Yandell
-
Forward Look
Determining ValueNew tools offer a cost-benefit analysis of cancer treatments.
by Stephen Ornes
Cancer Talk
Treating Smoldering Multiple Myeloma
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona